Status:
UNKNOWN
GnRHa for Luteal Phase Support in GnRH Antagonist Protocol Cycles
Lead Sponsor:
Mansoura University
Conditions:
Infertility
Eligibility:
FEMALE
20-38 years
Phase:
PHASE4
Brief Summary
Evaluation of the effect of adding a single dose of gonadotropin releasing hormone agonist (GnRHa) as a luteal phase support on the outcomes of intracytoplasmic sperm injection (ICSI) following GnRH a...
Detailed Description
Endometrial preparation for embryo transfer (ET) will be started after oocyte retrieval by giving 800 mg/day natural progesterone vaginal supplement + 4 mg/day estradiol oral supplement. The patients ...
Eligibility Criteria
Inclusion
- Women subjected to ICSI through controlled ovarian hyperstimulation (COH) with pituitary downregulation by GnRH antagonist.
Exclusion
- Moderate or severe endometriosis.
- Hydrosalpinx.
- Uterine abnormalities.
- Myoma.
- Previous uterine surgery.
Key Trial Info
Start Date :
August 7 2016
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT02312089
Start Date
August 7 2016
End Date
December 31 2024
Last Update
October 30 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Fertility Care Unit (FCU) in Mansoura University Hospital
Al Mansurah, Dakahlia Governorate, Egypt, 35111
2
Private fertility care centers
Al Mansurah, Dakahlia Governorate, Egypt